Cabaletta Bio Inc (CABA)
$2.82 -$0.12 (-4.08%) 10:16 PM 12/14/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$137.83M -
Day's Range
$2.75 - $2.98 -
Volume
5,751,939 -
52 Week Low / High
$1.76 - $26.35 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 10
- Strong Buy
- 2
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $25.29
- Target Price
Company News
-
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024
Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...
-
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024
Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...
-
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024
Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...
-
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024
Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...
-
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024
Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...
-
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024
Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...
-
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024
Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...
-
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024
Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...
-
State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings — Oct 17th, 2024
Overview of Recent Transaction On September 30, 2024, State Street Corp executed a significant transaction by reducing its holdings in Cabaletta Bio Inc (NASDAQ:CABA), a clinical-stage biotechnology company. The firm sold 1,109,678 shares at a price of $4.72 each, resulting in a remaining...
Portfolio
Comprised of 1 portfolios